Seminars in radiation oncology
Journal of radiation oncology
Over the last two decades, radiation therapy for early stage nonsmall cell lung cancer has progressed to increasingly hypofractionated treatment courses. Stereotactic body radiotherapy, which is now the standard of care for medically inoperable patients and a treatment choice for operable patients, produces results similar to surgical resection. The best radiation dose and fractionation are still being worked out, especially for central tumors, which have higher treatment toxicity than peripheral tumors…
Particle therapy’s dosimetric benefits result in a slightly lower integral dosage to normal tissues, making it an appealing treatment choice for body locations like the thorax. Dose amplification, toxicity reduction, or hypofractionation are both possibilities when normal tissue dose is decreased. Although proton and heavy ion therapy have been widely used for NSCLC, preparation and delivery problems exist as compared to X-ray-based radiation therapy. Range uncertainties, which are exacerbated by breathing motion, must be taken into account. ..
Hot topics in radiation oncology
The collection of journals was ranked and divided into four equal classes, or quartiles, based on their SJR. The highest values are in Q1 (green), followed by the second highest values in Q2 (yellow), the third highest values in Q3 (orange), and the lowest values in Q4 (red).
The SJR is a prestige metric that rates journals based on their ‘average prestige per paper’ regardless of their size. It is founded on the principle that “not all citations are created equal.” SJR is a measure of a journal’s scientific impact that takes into account both the amount of citations it receives and the importance or reputation of the journals from which those citations come.
This indicator divides the total number of citations earned by the total number of documents published in a journal by the total number of documents published in that journal. The graph depicts how the total number of times documents published in a journal in the previous two, three, and four years have been referenced in the current year has changed over time. The two-year line corresponds to the TM (Thomson Reuters) journal impact factor metric.
New topics in radiation therapy
5.7 in 2019
Seminars in radiation oncology abbreviation
The average number of citations obtained per peer-reviewed paper published in this title is calculated using CiteScore. Citation counts of peer-reviewed documents (articles, reports, conference papers, data papers, and book chapters) published in the same four calendar years (e.g. 2016 – 2019) are separated by the number of these documents published in the same four calendar years (e.g. 2016 – 19).
A guest editor compiles each issue of Seminars in Radiation Oncology to discuss a particular topic in the specialty, providing authoritative information on areas of rapid change and growth. A large number of publications present new research findings. Tumor biology is one of the topics covered…
A guest editor compiles each issue of Seminars in Radiation Oncology to discuss a particular topic in the specialty, providing authoritative information on areas of rapid change and growth. A large number of publications present new research findings. Tumor genetics, diagnosis, medical and surgical treatment of the patient, and emerging developments are all addressed. Hide the entire Aims & Scope section.
Seminars in radiation oncology sbrt
Note: The impact factor shown here is similar to citescore and is hence used as a substitute for it. Scopus calculates Citescore, which can be slightly higher or lower than the impact factor calculated by Journal Citation Report. Please verify the exact journal impact factor TM (Thomson Reuters) metric using the Web of Science data base.
Seminars in Radiation Oncology is a journal that covers oncology (Q1), radiology, nuclear medicine, and imaging (Q1), and cancer research (Q1) methods, areas, and categories (Q2). W. B. Saunders Co., Ltd. is the publisher. Seminars in Radiation Oncology is ranked 2354th in the world.
This journal is ranked 1.465 in the SCImago Journal Rating (SJR). The SCImago Journal Rank is a metric that assesses a journal’s scientific impact. It takes into account the amount of citations a journal receives as well as the relevance of the journals from which these citations originate. SJR is a substitute for the Journal Impact Factor (or an average number of citations received in last 2 years). The h-index of this journal is 84. Q1 is the best quartile for this journal.